Tumor inductions by cytostatics in man.
D015081:2-Naphthylamine / Q000009:adverse effects / Q000031:analogs & derivatives; D000477:Alkylating Agents / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002066:Busulfan / Q000009:adverse effects; D002273:Carcinogens; D003043:Cocarcinogenesis; D003520:Cyclophosphamide / Q000009:adverse effects; D005260:Female; D006689:Hodgkin Disease / Q000628:therapy; D006801:Humans; D007938:Leukemia / Q000628:therapy; D008297:Male; D008558:Melphalan / Q000009:adverse effects; D009369:Neoplasms / Q000139:chemically induced*; D009588:Nitrogen Mustard Compounds / Q000009:adverse effects; D011878:Radiotherapy / Q000009:adverse effects; D013997:Time Factors
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D002273:Carcinogens; D009588:Nitrogen Mustard Compounds; D003520:Cyclophosphamide; D015081:2-Naphthylamine; D002066:Busulfan; D008558:Melphalan